95 related articles for article (PubMed ID: 10976283)
1. [A comparative evaluation of treatment methods for a genital papillomavirus infection in women with different viral genotypes].
Mikhaĭlov IG; Maksimov SIa; Novik VI; Safronnikova NR; Vishnevskiĭ AS; Prianishnikov VA; Lyshev AA
Vopr Onkol; 2000; 46(3):340-3. PubMed ID: 10976283
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human papillomavirus gynecologic infections.
Auborn KJ; Carter TH
Clin Lab Med; 2000 Jun; 20(2):407-22. PubMed ID: 10863647
[TBL] [Abstract][Full Text] [Related]
3. [Combination of beta-interferon and laser-CO2 therapy in female HPV genitalis].
Facchini C; Eremita GA; Bernabei A
Minerva Ginecol; 1996 Sep; 48(9):345-9. PubMed ID: 8999380
[TBL] [Abstract][Full Text] [Related]
4. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
5. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
6. [Beta-interferon treatment of HPV infections of the lower genital tract in women].
Bernasconi F; Gritti P; Ersettigh G; Galli F; Arienti S
Minerva Ginecol; 1994 Nov; 46(11):609-18. PubMed ID: 7854565
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
8. [Human papilloma virus infections in gynecology].
Damianov L; Damianova V; Zakharieva B
Akush Ginekol (Sofiia); 2006; 45 Suppl 2():14-6. PubMed ID: 16922339
[No Abstract] [Full Text] [Related]
9. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
Schiffman M; Wheeler CM; Castle PE;
J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
[TBL] [Abstract][Full Text] [Related]
11. [Detection and typing by molecular biology of human papillomavirus in genital samples].
Suárez Moya A; Esquivias Gómez JI; Vidart Aragón JA; Picazo de la Garza JJ
Rev Esp Quimioter; 2006 Jun; 19(2):161-6. PubMed ID: 16964334
[TBL] [Abstract][Full Text] [Related]
12. Determinants of genital human papillomavirus detection in a US population.
Peyton CL; Gravitt PE; Hunt WC; Hundley RS; Zhao M; Apple RJ; Wheeler CM
J Infect Dis; 2001 Jun; 183(11):1554-64. PubMed ID: 11343204
[TBL] [Abstract][Full Text] [Related]
13. Human papilloma virus associated with genital infection.
Ljubojević S; Lipozencić J; Grgec DL; Prstacić R; Skerlev M; Mokos ZB
Coll Antropol; 2008 Sep; 32(3):989-97. PubMed ID: 18982779
[TBL] [Abstract][Full Text] [Related]
14. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong.
Chan PK; Mak KH; Cheung JL; Tang NL; Chan DP; Lo KK; Cheng AF
J Med Virol; 2002 Oct; 68(2):273-7. PubMed ID: 12210419
[TBL] [Abstract][Full Text] [Related]
15. [Genital bacterial infections associated with papillomavirus: value of screening and basis for treatment].
Aynaud O; Bijaoui G; Huynh B
Contracept Fertil Sex; 1993 Feb; 21(2):149-52. PubMed ID: 7951605
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
[TBL] [Abstract][Full Text] [Related]
18. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients.
Brown MR; Noffsinger A; First MR; Penn I; Husseinzadeh N
Gynecol Oncol; 2000 Nov; 79(2):220-4. PubMed ID: 11063648
[TBL] [Abstract][Full Text] [Related]
19. Papilloma virus and c-erbB-2 expression in diseases of the mammary nipple.
Manavi M; Baghestanian M; Kucera E; Berger A; Schatten C; Pischinger K; Czerwenka K
Anticancer Res; 2001; 21(1B):797-801. PubMed ID: 11299846
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
